Integrated research, development, and high-purity clinical-grade botanical manufacturing.
In the global health and wellness matrix, biological compounds sourced from standard natural matrices are gaining unprecedented traction. Specifically, Acillin (an stabilized active formulation derivative of Allicin, the organosulfur compound obtained from *Allium sativum*) represents the cutting edge of cardiovascular defense, antimicrobial applications, and immune modulation. However, the commercial manufacturing of Acillin garlic extracts is plagued by chemical instability, volatility, and degradation under thermal or atmospheric exposure.
As a leading B2B global enterprise, we address critical manufacturing pain points. Typical ODM buyers encounter variations in biological efficacy across harvests. By partnering with standard-aligned Chinese agro-industrial zones, we secure stable raw material pipelines. This structural vertical integration ensures that every micro-gram of Acillin garlic powder maintains molecular uniformity, fulfilling the strict requirements of pharmaceutical, food supplement, and cosmetic formulators worldwide.
Our extraction methodologies rely on cold-process multi-stage separation. By neutralizing the *alliinase* enzyme dynamically under pressure and reconstituting it during human ingestion through enteric-coated capsule formulations, we bypass stomach-acid inactivation. This technical advancement makes our raw materials the prime choice for pharmaceutical-grade cardiovascular supplements targeting micro-circulation, lipid management, and vascular wall protection.
The global industrial footprint for premium garlic derivatives is transitioning from commodity-grade agricultural powders to high-value active nutraceutical ingredients (ANIs). Current market data suggests a compound annual growth rate (CAGR) of 6.8% for standardized Allicin and Acillin complexes, with the European Union and North America accounting for over 55% of overall market demand. This demand is increasingly driven by consumers seeking natural alternatives to conventional synthetics for blood pressure maintenance and gut microbiome support.
Historically, supply chains were concentrated around simple dehydrated garlic flakes. However, advanced manufacturers require precision-engineered extracts. To control costs, high-efficiency ODM garlic factories must establish facilities close to cultivation origins. This proximity minimizes raw material oxidation and carbon footprints during transit. Our primary processing units are located adjacent to organic agricultural cooperatives, allowing for immediate milling and cold-chain stabilization within six hours of harvesting.
Chengdu ChenLv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Why leading global brands choose Chenlv Herb for custom botanical sourcing and contract manufacturing.
Chenlv Herb provides comprehensive contract manufacturing services to bring your customized products to market.
Communicate with customers to determine product specifications and extract profiles.
Provide a detailed proposal and customized price list based on target active ingredient markers.
Execute formal agreements outlining delivery timelines and purity guarantees.
Formulate and test prototypes in our state-of-the-art analytical laboratory.
After customer approval of samples, schedule high-capacity extract runs.
Perform complete quality control testing to issue official certificates of analysis (COA).
Secure global shipping and logistics management directly from our factory doors.
Unlocking the potential of biological extracts across consumer sectors.
Acillin standardization is managed under GMP-level protocols. Our technical roadmap centers on two primary goals: maximum chemical preservation and complete matrix safety. To accomplish this, our research division implements supercritical CO2 extraction systems alongside high-efficiency separation processes. This pathway eliminates chemical residues associated with traditional organic solvents, maintaining clean-label integrity across overseas regulatory markets.
We actively comply with the global certifications requested by top-tier importers. Our primary manufacturing facility maintains clean operations verified by global standards:
Our ongoing development centers on micro-encapsulation techniques. Through this, we coat volatile allicin molecules inside a protective organic cyclodextrin shell. This structural breakthrough increases shelf-life stability to 36 months, protecting raw materials against humidity changes and heat fluctuations during global container shipments.
Technical answers to support procurement managers, quality assurance leads, and formulators.
Our quality system is verified by international food safety and quality frameworks.
Market movements, botanical price dynamics, and international pharmaceutical events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end and new supplies enter the market, price fluctuations have become a focal point due to supply and demand dynamics.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to present new biotech innovations.
The 92nd China International Pharmaceutical Raw Materials / Intermediates / Packaging / Equipment Fair (API China) will grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou, highlighting clean-process ingredients.
Premium natural compounds for customized health solutions, manufactured under strict clinical compliance.